{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:45:07Z","timestamp":1790027107441,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T00:00:00Z","timestamp":1326240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Insulin resistance and metabolic syndrome are chronic inflammatory conditions that lead to hepatic injury and non-alcoholic steatohepatitis (NASH). Bovine colostrum has therapeutic effects in a variety of chronic infections. However its effectiveness in NASH was never studied. Natural killer T (NKT) cells have been shown to be associated with some of the pathological and metabolic abnormalities accompanying NASH in leptin-deficient (ob\/ob) mice. In the present study, we used hyperimmune bovine colostrum to treat hepatic injury and insulin resistance and we also assessed the effects on NKT cells. We used ob\/ob mice that were fed for 6 weeks with either 0\u00b71\u2003mg bovine colostrum prepared from non-immunized cows, 0\u00b71\u2003mg hyperimmune colostrum raised against a bacterial lipopolysaccharide (LPS) extract or 0\u00b7001, 0\u00b71 or 1\u2003mg of immunoglobulin (Ig)G purified from hyperimmune colostrum (IgG\u2013LPS). NKT cells were phenotyped by flow cytometry, and hepatic injury and insulin resistance were assessed by measuring fasting glucose levels, glucose tolerance tests and liver enzymes. Fat accumulation was measured in the liver and plasma. Oral administration of hyperimmune colostrums decreased alanine aminotransferase (ALT) serum levels and serum triglycerides compared to controls. Glucose intolerance was also improved by the hyperimmune colostrum preparations. These results were accompanied by a decrease in serum tumour necrosis factor (TNF)-\u03b1 levels following oral treatment with 0\u00b71 or 1\u2003mg of IgG\u2013LPS. The beneficial effects of hyperimmune colostrums were associated with an increase in the number of splenic NKT cells. These data suggest that oral administration of hyperimmune colostrum preparations can alleviate chronic inflammation, liver injury and insulin resistance associated with NASH.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04511.x","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T11:51:14Z","timestamp":1319802674000},"page":"252-260","source":"Crossref","is-referenced-by-count":64,"title":["Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells"],"prefix":"10.1093","volume":"167","author":[{"given":"T","family":"Adar","sequence":"first","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ben Ya'acov","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lalazar","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Lichtenstein","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nahman","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mizrahi","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Wong","sequence":"additional","affiliation":[{"name":"Immuron Limited, North Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Muller","sequence":"additional","affiliation":[{"name":"Immuron Limited, North Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rawlin","sequence":"additional","affiliation":[{"name":"Immuron Limited, North Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ilan","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,11]]},"reference":[{"key":"2021122708460092900_b1","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","article-title":"Inflammatory pathways and insulin action","volume":"27","author":"Hotamisligil","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2021122708460092900_b2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"2021122708460092900_b3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine\u2013adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"2021122708460092900_b4","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2337\/diabetes.51.10.2951","article-title":"Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?","volume":"51","author":"Gabriely","year":"2002","journal-title":"Diabetes"},{"key":"2021122708460092900_b5","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"2021122708460092900_b6","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi","year":"1999","journal-title":"Circulation"},{"key":"2021122708460092900_b7","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021122708460092900_b8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin\u2003\u2013\u2003journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J Intern Med"},{"key":"2021122708460092900_b9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jhep.2009.02.032","article-title":"Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model","volume":"51","author":"Kudo","year":"2009","journal-title":"J Hepatol"},{"key":"2021122708460092900_b10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MCG.0b013e3181e12c24","article-title":"Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis","volume":"45","author":"Verdam","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"2021122708460092900_b11","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s11695-007-9243-7","article-title":"Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis","volume":"17","author":"Ruiz","year":"2007","journal-title":"Obes Surg"},{"key":"2021122708460092900_b12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"2021122708460092900_b13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u2018hits\u2019","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"2021122708460092900_b14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hep.510310313","article-title":"Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage","volume":"31","author":"Guebre-Xabier","year":"2000","journal-title":"Hepatology"},{"key":"2021122708460092900_b15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.20320","article-title":"Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis","volume":"40","author":"Li","year":"2004","journal-title":"Hepatology"},{"key":"2021122708460092900_b16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.1069017","article-title":"A thymic precursor to the NK T cell lineage","volume":"296","author":"Benlagha","year":"2002","journal-title":"Science"},{"key":"2021122708460092900_b17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1053\/gast.2002.35997","article-title":"Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system","volume":"123","author":"Li","year":"2002","journal-title":"Gastroenterology"},{"key":"2021122708460092900_b18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CPP45193","article-title":"Bovine colostrum as a biologic in clinical medicine: a review. Part I: biotechnological standards, pharmacodynamic and pharmacokinetic characteristics and principles of treatment","volume":"45","author":"Struff","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2021122708460092900_b19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5414\/CPP46211","article-title":"Bovine colostrum as a biologic in clinical medicine: a review\u2003\u2013\u2003Part II: clinical studies","volume":"46","author":"Struff","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2021122708460092900_b20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0264-410X(97)00027-3","article-title":"Generation of bovine immune colostrum against Streptococcus mutans and Streptococcus sobrinus and its effect on glucose uptake and extracellular polysaccharide formation by mutans streptococci","volume":"15","author":"Loimaranta","year":"1997","journal-title":"Vaccine"},{"key":"2021122708460092900_b21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/00222615-48-10-917","article-title":"Colostral proteins from cows immunised with Streptococcus mutans\/S. sobrinus support the phagocytosis and killing of mutans streptococci by human leucocytes","volume":"48","author":"Loimaranta","year":"1999","journal-title":"J Med Microbiol"},{"key":"2021122708460092900_b22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ajcn\/52.6.1014","article-title":"Cholesterol-lowering effect of skim milk from immunized cows in hypercholesterolemic patients","volume":"52","author":"Golay","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"2021122708460092900_b23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1152\/jappl.1997.83.4.1144","article-title":"Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training","volume":"83","author":"Mero","year":"1997","journal-title":"J Appl Physiol"},{"key":"2021122708460092900_b24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/10408690490911756","article-title":"Milk biologically active components as nutraceuticals: review","volume":"45","author":"Severin","year":"2005","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2021122708460092900_b25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1203\/00006450-199807000-00006","article-title":"Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity","volume":"44","author":"Buescher","year":"1998","journal-title":"Pediatr Res"},{"key":"2021122708460092900_b26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000014019","article-title":"Cytokines, chemokines, and colony-stimulating factors in human milk: the 1997 update","volume":"74","author":"Garofalo","year":"1998","journal-title":"Biol Neonate"},{"key":"2021122708460092900_b27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0031-3955(05)70283-2","article-title":"Anatomy and physiology of lactation","volume":"48","author":"Neville","year":"2001","journal-title":"Pediatr Clin North Am"},{"key":"2021122708460092900_b28","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1017\/S0007114500002282","article-title":"Milk immunoglobulins and complement factors","volume":"84","author":"Korhonen","year":"2000","journal-title":"Br J Nutr"},{"key":"2021122708460092900_b29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/156.1.158","article-title":"Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants","volume":"156","author":"Hilpert","year":"1987","journal-title":"J Infect Dis"},{"key":"2021122708460092900_b30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diab.39.9.1028","article-title":"IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM","volume":"39","author":"Dohm","year":"1990","journal-title":"Diabetes"},{"key":"2021122708460092900_b31","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/diabetes.51.6.1876","article-title":"Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity","volume":"51","author":"Xu","year":"2002","journal-title":"Diabetes"},{"key":"2021122708460092900_b32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.20283","article-title":"Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway","volume":"40","author":"Feldstein","year":"2004","journal-title":"Hepatology"},{"key":"2021122708460092900_b33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1476-511X-9-82","article-title":"Endotoxin levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects","volume":"9","author":"Lira","year":"2010","journal-title":"Lipids Health Dis"},{"key":"2021122708460092900_b34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.21750","article-title":"Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis","volume":"46","author":"Ewaschuk","year":"2007","journal-title":"Hepatology"},{"key":"2021122708460092900_b35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000231910","article-title":"Proteolysis of bovine immunoglobulins","volume":"55","author":"de Rham","year":"1977","journal-title":"Int Arch Allergy Appl Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04511.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/167\/2\/252\/41907579\/j.1365-2249.2011.04511.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/167\/2\/252\/41907579\/j.1365-2249.2011.04511.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:18:41Z","timestamp":1641053921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/167\/2\/252\/6422805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,11]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,1,11]]},"published-print":{"date-parts":[[2012,1,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04511.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2]]},"published":{"date-parts":[[2012,1,11]]}}}